Nintedanib solid lipid nanoparticles improve oral bioavailability and ameliorate pulmonary fibrosis in vitro and in vivo models
Rajwinder Kaur, Taslim B. Shaikh, Hari Priya Sripadi, Madhusudana Kuncha, U.V.R. Vijaya Sarathi, Hitesh Kulhari, Sai Balaji Andugulapati, Ramakrishna Sistla
Topics & Concepts
PirfenidoneNintedanibPharmacologyBioavailabilityIdiopathic pulmonary fibrosisSolid lipid nanoparticleIn vivoFibrosisPulmonary fibrosisMedicinePharmacokineticsBleomycinLungDrugPathologyInternal medicineChemotherapyBiologyBiotechnologyInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisInhalation and Respiratory Drug Delivery